The purposes of this study are to determine:
- The effects of arzoxifene on bone mineral density (bone mass) at the spine and hip in
postmenopausal women.
- The effects of arzoxifene on the uterus (womb) in postmenopausal women.
- The effects of arzoxifene on blood tests that measure changes in bone rebuilding in
postmenopausal women with low bone density.
- The effects of arzoxifene on blood lipids (fats) and other blood markers of heart
disease risk.
- The safety of arzoxifene and any side effects that might be associated with its use.